Tag: post-approval drug monitoring
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Categories
Archives
Recent-posts
Antibiotic Resistance: Understanding Why Your Medication Changes and New Treatment Choices
Apr, 26 2025

Medications